556
Views
0
CrossRef citations to date
0
Altmetric
Correction

Correction

This article refers to:
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force report

Article title: Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force report

Authors: Joudrey, P. J., Bart, G., Brooner, R. K., Brown, L., Dickson-Gomez, J., Gordon, A., Kawasaki, S. S., Liebschutz, J. M., Nunes, E., McCarty, D., Schwartz, R. P., Szapocnik, J., Trivedi, M., Tsui, J. I., Williams, A., Wu, L-T. & Fiellin, D. A.

Journal: Substance Abuse

Bibliometrics: Volume 42, Number 3, pages 245–254

DOI: https://doi.org/10.1080/08897077.2021.1975344

Center for Clinical Trials Network (CCTN) has been corrected to Clinical Trials Network (CTN) in the article title and text.

The corrected article title is:

Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force report

Center for Clinical Trials Network has been corrected to Clinical Trials Network on pages 245, 246, and 252.

CCTN has been corrected to CTN on pages 246, 247, and 252.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.